During the past decade, Medical Corporation Shinanokai Shinanozaka Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Corporation Shinanokai Shinanozaka Clinic" #1 collaborator was "Japan Agency for Medical Research and Development" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medical Corporation Shinanokai Shinanozaka Clinic" are "COVID-19" (1 trials), "COVID-19 Lower Respiratory Infection" (1 trials), "Healthy" (1 trials) and "Safety and Pharmacokinetics" (1 trials). Many other conditions were trialed in "Medical Corporation Shinanokai Shinanozaka Clinic" in a lesser frequency.

Most popular intervention types in "Medical Corporation Shinanokai Shinanozaka Clinic" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "AG0302-COVID19 for Intradermal Injection" (1 trials), "AG0302-COVID19 for Intramuscular Injection" (1 trials), "Group A (AG0302-COVID19)" (1 trials), "Group A (Placebo)" (1 trials) and "Group B (AG0302-COVID19)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Corporation Shinanokai Shinanozaka Clinic" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Corporation Shinanokai Shinanozaka Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Medical Corporation Shinanokai Shinanozaka Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Corporation Shinanokai Shinanozaka Clinic, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".